Mesoblast (MESO) Interest & Investment Income (2014 - 2022)
Mesoblast (MESO) posted Interest & Investment Income of $60000.0 for Q3 2022, up 140.0% sequentially from $25000.0 in Q2 2022, and up 475.0% YoY from $10434.8 in Q3 2021.
Mesoblast (MESO) Interest & Investment Income (2014 - 2022) Analysis & Trends
Mesoblast has reported Interest & Investment Income for 9 years, with the latest figure at $60000.0 in Q3 2022.
- Quarterly Interest & Investment Income rose 475.0% year-over-year to $60000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $79000.0 (up 890.0% YoY) and the FY2022 annual result came in at $3000.0, down 86.36% from the prior year.
- Interest & Investment Income advanced to $60000.0 in Q3 2022 per MESO's latest filing, from $25000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $237000.0 in Q4 2019 and troughed at -$16000.0 in Q3 2021.
- A 5-year average of $80526.3 and a median of $60000.0 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2021 and 2022: Interest & Investment Income plunged 200.0% in 2021, then jumped 2600.0% in 2022.
- Over 5 years, Interest & Investment Income stood at $153000.0 in 2018, then surged by 54.9% to $237000.0 in 2019, then sank by 97.89% to $5000.0 in 2020, then sank by 180.0% to -$4000.0 in 2021, then jumped by 1600.0% to $60000.0 in 2022.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $60000.0, $25000.0, and -$2000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 120,000.00 |
| Dec 31, 2019 | 237,000.00 |
| Sep 30, 2019 | 176,000.00 |
| Jun 30, 2019 | 228,000.00 |
| Mar 31, 2019 | 207,000.00 |
| Dec 31, 2018 | 153,000.00 |
| Sep 30, 2018 | 131,000.00 |
| Jun 30, 2018 | 105,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Dec 31, 2017 | 114,000.00 |